BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9216647)

  • 1. Transformation of human glioma cell lines with the p16 gene inhibits cell proliferation.
    Hama S; Sadatomo T; Yoshioka H; Kurisu K; Tahara E; Naruse I; Heike Y; Saijo N
    Anticancer Res; 1997; 17(3C):1933-8. PubMed ID: 9216647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth.
    Arap W; Nishikawa R; Furnari FB; Cavenee WK; Huang HJ
    Cancer Res; 1995 Mar; 55(6):1351-4. PubMed ID: 7882335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p16(INK4A) induces dominant suppression of glioblastoma growth in situ through necrosis and cell cycle arrest.
    Hung KS; Hong CY; Lee J; Lin SK; Huang SC; Wang TM; Tse V; Sliverberg GD; Weng SC; Hsiao M
    Biochem Biophys Res Commun; 2000 Mar; 269(3):718-25. PubMed ID: 10720483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletions and rearrangements inactivate the p16INK4 gene in human glioma cells.
    Srivenugopal KS; Ali-Osman F
    Oncogene; 1996 May; 12(9):2029-34. PubMed ID: 8649864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staurosporine-induced apoptosis is independent of p16 and p21 and achieved via arrest at G2/M and at G1 in U251MG human glioma cell line.
    Yamasaki F; Hama S; Yoshioka H; Kajiwara Y; Yahara K; Sugiyama K; Heike Y; Arita K; Kurisu K
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):271-83. PubMed ID: 12721754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells.
    Fueyo J; Gomez-Manzano C; Yung WK; Clayman GL; Liu TJ; Bruner J; Levin VA; Kyritsis AP
    Oncogene; 1996 Jan; 12(1):103-10. PubMed ID: 8552379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibitory effect on glioma cells of adenovirus-mediated p16/INK4a gene transfer in vitro and in vivo.
    Lee SH; Kim MS; Kwon HC; Park IC; Park MJ; Lee CT; Kim YW; Kim CM; Hong SI
    Int J Mol Med; 2000 Nov; 6(5):559-63. PubMed ID: 11029524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors.
    Kuerbitz SJ; Malandro J; Compitello N; Baylin SB; Graff JR
    Cell Growth Differ; 1999 Jan; 10(1):27-33. PubMed ID: 9950215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of p16INK4a on chemosensitivity in nasopharyngeal carcinoma cells.
    Chow LS; Wang X; Kwong DL; Sham JS; Tsao SW; Nicholls JM
    Int J Oncol; 2000 Jul; 17(1):135-40. PubMed ID: 10853030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticancer drug induced sister chromatid exchange and correlation to cell survival in human brain tumor cells].
    Aida T; Bodell WJ
    No To Shinkei; 1987 Mar; 39(3):235-41. PubMed ID: 3472531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemoresistance to cisplatin and paclitaxel.
    Grim J; D'Amico A; Frizelle S; Zhou J; Kratzke RA; Curiel DT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2415-23. PubMed ID: 9815642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas.
    Harada H; Nakagawa K; Iwata S; Saito M; Kumon Y; Sakaki S; Sato K; Hamada K
    Cancer Res; 1999 Aug; 59(15):3783-9. PubMed ID: 10446996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated p16 gene transfer prevents drug-induced cell death through G1 arrest in human glioma cells.
    Hama S; Heike Y; Naruse I; Takahashi M; Yoshioka H; Arita K; Kurisu K; Goldman CK; Curiel DT; Saijo N
    Int J Cancer; 1998 Jul; 77(1):47-54. PubMed ID: 9639393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.
    Schmid M; Sen M; Rosenbach MD; Carrera CJ; Friedman H; Carson DA
    Oncogene; 2000 Nov; 19(50):5747-54. PubMed ID: 11126361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro.
    Liggett WH; Sewell DA; Rocco J; Ahrendt SA; Koch W; Sidransky D
    Cancer Res; 1996 Sep; 56(18):4119-23. PubMed ID: 8797577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro.
    Chintala SK; Fueyo J; Gomez-Manzano C; Venkaiah B; Bjerkvig R; Yung WK; Sawaya R; Kyritsis AP; Rao JS
    Oncogene; 1997 Oct; 15(17):2049-57. PubMed ID: 9366522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
    Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
    Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.